Cardiovascular Diabetology | |
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof | |
关键词: Atherosclerosis; Coronary artery disease; Cytokines; Diabetes mellitus; Interleukins; | |
DOI : 10.1186/1475-2840-2-11 | |
来源: DOAJ |
【 摘 要 】
Abstract
Background
The impressive correlation between cardiovascular disease and glucose metabolism alterations has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Inflammation is emerging as a conceivable etiologic mechanism for both. Interleukins are regulatory proteins with ability to accelerate or inhibit inflammatory processes.
Presentation of the hypothesis
A novel interleukins classification is described, based on their role in diabetes and atherosclerosis, hypothesizing that each interleukin (IL) acts on both diseases in the same direction – regardless if harmful, favorable or neutral.
Testing the hypothesis
The 29 known interleukins were clustered into three groups:
Implications
These observations imply that 1) favorable effects of a given IL on either diabetes or atherosclerosis predicts similar effects on the other; 2) equally, harmful IL effects on one disease can be extrapolated to the other; and 3) absence of influence of a given IL on one of these diseases forecasts lack of effects on the other. These facts further support the unifying etiologic theory of both ailments, emphasizing the importance of a cardiovascular diabetologic approach to interleukins for future research. Pharmacologic targeting of these cytokines might provide an effective means to simultaneously control both atherosclerosis and diabetes.
【 授权许可】
Unknown